Surgery beats standard therapy after 5 years for T2DM
Metabolic or bariatric surgery may be more effective than standard medical treatments for the long-term control of type 2 diabetes in obese patients, according to a study by King’s College London and the Universita Cattolica in Rome, Italy. The study, ‘Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial’, published in the Lancet, is the first to provide data on five-year outcomes of surgery from a randomised clinical trial specifically designed to compare this new approach against standard medical therapy for the treatment of type 2 diabetes.